Quinonic derivatives active against a virulent strain of Toxoplasma gondii. Synthesis of 2-methylfuro[2,3-g]- and [3,2-g]isoquinolinetriones

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 9, 2000, Pages 871-873

  Nebois, Pascal ^a   Sarciron, Marie Elizabeth ^a   Bibal, Brigitte ^a   Bouammali, Boufelja ^a   Cherkaoui, Omar ^a   Pautet, Félix ^a   Pétavy, Anne Françoise ^a   Walchshofer, Nadia ^a   Fillion, Houda ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLFURO[2,3 G]ISOQUINOLONE 4,7,9 TRIONE; 2 METHYLFURO[3,2 G]ISOQUINOLONE 4,6,9 TRIONE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG SYNTHESIS; GROWTH INHIBITION; HUMAN; IN VITRO STUDY; LEUKEMIA CELL LINE; NONHUMAN; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TOXOPLASMA GONDII;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; FURANS; HUMANS; MONOCYTES; QUINOLINES; TOXOPLASMA;

PROTOZOA; TOXOPLASMA GONDII;

EID: 0034192528     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00112-8     Document Type: Article

References (15)

1. Holliman R.E. J. Infect. 35:1997;105.
2. Dar F.K., Alkarmi T., Uduman S., Abdulrazzaq Y., Grundsell H., Hughes P. Eur. J. Epidemiol. 13:1997;567.
3. Dunn D., Wallon M., Peyron F., Peterson C., Peckam C., Gilbert R. Lancet. 353:1999;1829.
4. Kaplan J.E., Masur H., Jaffe H.W., Holmes K.K. JAMA. 278:1997;337.
5. Sarciron M.E., Walchshofer N., Paris J., Pétavy A.F., Peyron F. Parasite. 5:1998;359.
6. Ribeiro-Rodriguez, R; dos Santos, W. G.; Oliveira, A. B.; Snieckus, V.; Zani, C. L.; Romanha, A. J. Bioorg. Med. Chem. Lett. 1995, 5, 1509 and references cited therein.
7. Bouammali B., Pautet F., Carneiro de Nascimento S., Boitard M., Fillion H. Arch. Pharm. 326:1993;499.
8. Bouammali B., Pautet F., Fillion H., Soufiaoui M. Tetrahedron. 49:1993;3125.
9. Cherkaoui O., Nebois P., Fillion H., Domard M., Fenet B. Tetrahedron. 52:1996;9499.
10. Grunwell J.R., Karipides A., Wigal C.T., Heinzman S.W., Parlow J., Surso J.A., Clayton L., Freitz F., Daffner M., Stevens J.E. J. Org. Chem. 56:1991;91.
11. Bayard, P.; Sainte, F.; Beaudegnies, R.; Ghosez, L. Tetrahedron Lett. 1988, 29, 3799. Ghosez, L.; Bayard, P.; Nshimyumukiza, P.; Gouverneur, V.; Sainte, F.; Beaudegnies, R.; Rivera, M.; Frisque-Hesbain, A.-M.; Wynants, C. Tetrahedron 1995, 51, 11021.
12. Bayard, P.; Sainte, F.; Beaudegnies, R.; Ghosez, L. Tetrahedron Lett. 1988, 29, 3799. Ghosez, L.; Bayard, P.; Nshimyumukiza, P.; Gouverneur, V.; Sainte, F.; Beaudegnies, R.; Rivera, M.; Frisque-Hesbain, A.-M.; Wynants, C. Tetrahedron 1995, 51, 11021.
13. Poumaroux A., Bouaziz Z., Fillion H., Domard M., Giraud J., Pétavy A.F. Chem. Pharm. Bull. 47:1999;643.
14. Cherkaoui O., Nebois P., Fillion H. Chem. Pharm. Bull. 45:1997;457.
15. Araujo F.G., Khan A.A., Remington J.S. Antimicrob. Agents Chemother. 40:1996;1335.